The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Borrower

O•• L•• O•••• B••••• L••

Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed

What matters now

  1. 99¢ → 92¢
    consensus mark

    Consensus mark 92¢ on cost, down from 99¢ a year ago, 94¢ last quarter.

    Q2 2026 · The lenders' own valuations, the most direct read of what they expect to recover.

    Derived2 of 2 lenders' own marks, weighted by principal
Mark path, consensus per quarter end
Q2 2025: 99¢Q3 2025: 98¢Q4 2025: 97¢Q1 2026: 94¢Q2 2026: 92¢99¢ · 98¢ · 97¢ · 94¢ · 92¢Q2 2025 to Q2 2026
Where each lender marks it, 1 points apart
92¢Consensus: 92¢M••••• A••••• I••••••••• P•••••• L••••••: 93¢M••••• F•••••••• I••••••••• C•••: 92¢93¢
Principal held
at least $16.3M
sum of BDC pieces, a lower bound
Fair value
$14.8M
92c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
2
2 on the latest quarter
Facilities
3
0 equity pieces beside them
Next maturity
Jul 18, 2030
no dated debt inside 24 months
On the tape since
Sep 30, 2024
latest Jun 30, 2026
Events
8
dated, non-routine
Lender marks
each lender's own fair value over cost at Jun 30, 2026, folded to one row per lender
Every BDC piece · 4 positions across 2 lenderslargest principal first, with instrument and rate
BDCInstrumentPrincipalFair valueRate
M••••• A••••• I••••••••• P•••••• L••••••term loan first lien
F•••• L••• S•••••• D••• - T••• L••• S+500 (I•••••••• of 4.37% PIK), 1.00% F••••, M•••••••
$8.4M$7.7M
93c
SOFR+500 bp
PIK 4.37%
M••••• F•••••••• I••••••••• C•••term loan first lien
F•••• L••• S•••••• D••• – T••• L••• S•••+500 (I•••••••• of 4.37% PIK),, 1.00% F•••• M•••••
$6.6M$6.1M
93c
SOFR+500 bp
PIK 4.37%
M••••• F•••••••• I••••••••• C•••revolver first lien
F•••• L••• S•••••• D••• – R••••••• P+400, 1.00% F•••• M••••••• D••• 07/18/30
$1.1M$1.0M
91c
Prime+400 bp
M••••• A••••• I••••••••• P•••••• L••••••revolver first lien
F•••• L••• S•••••• D••• - R••••••• P+400, 1.00% F•••• M••••••• D••• 07/18/30
$80,000$71,000
90c
Prime+400 bp
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
FacilityHeldOn costPricingMaturityBDCs
first lien term loan first lienat least $15.1M93cSOFR+500 bp
PIK 4.37%
Jul 18, 20302
first lien revolver first lienat least $1.2M91cPrime+400 bpJul 18, 20302
first lien delayed draw term loan first lien
exited Mar 31, 2026
unknownn/aSOFR+500 bpJul 18, 20302
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20262$16.3M$14.8M92c2
Mar 31, 20262$17.0M$15.7M94c1
Dec 31, 20252$17.0M$16.1M96c0
Sep 30, 20251$8.3M$7.9M98c0
All 8 quarters
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20251$7.1M$6.8M98c0
Mar 31, 20251$7.2M$6.9M99c0
Dec 31, 20241$7.2M$7.0M100c0
Sep 30, 20241$6.9M$6.7M100c0
What changed
Full timeline · 15 events
Every change including routine ones
Identity
Group key
ORA ORIONderivedthe codename stem after legal suffixes and deal words
Spellings
1 across 2 BDCsderived
Industry
Pharmaceuticalsreportedas one filer wrote it